Print   

Thursday 27 August, 2009

Neuropharm Group PLC

Holding(s) in Company

RNS Number : 0791Y
Neuropharm Group PLC
27 August 2009
 




For immediate release 

27 August 2009



Neuropharm Group plc

('Neuropharm' or the 'Company')


TR-1: Notification of Major Interests in Shares


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Neuropharm Group plc

2. Reason for the notification  


An acquisition or disposal of voting rights

Yes

3. Full name of person(s) subject to the notification obligation:

Octopus Investments Nominees Limited   

4. Full name of shareholder(s) (if different from 3.):


5. Date of the transaction and date on which the threshold is crossed or reached:

25/08/2009

6. Date on which issuer notified:

26/08/2009

7. Threshold(s) that is/are crossed or reached:

3% to below notifiable %

8. Notified details:

n/a


A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Indirect

Direct

Indirect

GB00B1NPJJ01

1151429

1151429

901429

901429

-

2.86%

-


  

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument 

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted 

% of voting rights

-

-

-

-

-


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Number of voting rights instrument refers to


% of voting rights 


-

-

-

-

-


Total (A+B+C)

Number of voting rights

% of voting rights

901429

2.86%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

n/a


Proxy Voting:

10. Name of the proxy holder:

  n/a

11. Number of voting rights proxy holder will cease to hold:

  n/a

12. Date on which proxy holder will cease to hold voting rights:

  n/a  


13. Additional information:

  -

14. Contact name:

  Russell Jarvis

15. Contact telephone number:

   020 7710 8653


Annex Notification Of Major Interests In Shares

A: Identity of the person or legal entity subject to the notification obligation

Full name (including legal form for legal entities)

   Peter Orsi

Contact address (registered office for legal entities)

   8 Angel CourtLondonEC2R 7HP

Phone number 

  020 7710 8653

Other useful information (at least legal representative for legal persons)

  -


 

B:     Identity of the notifier, if applicable 

Full name 

   

Contact address 

   

Phone number 

   

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

   

 

C:    Additional information





This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNSKRKARWUAR

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.